Clinical trial
Renal Function Optimization With Mycophenolate Mofetil (MMF) Immunosuppressor…
NCT00290069 · Sociedad Andaluza de Trasplantes de Organos y Tejidos, Other · Unknown status
Key facts
| NCT number | NCT00290069 |
|---|---|
| Title | Renal Function Optimization With Mycophenolate Mofetil (MMF) Immunosuppressor Regimes (ALHAMBRA) |
| Official title | Comparative Study of Tacrolimus and Rapamycin to Evaluate the Renal Function in Patients Older Than 50 Years, Receptors of a Kidney From a Donor Older Than 55 Years in a Mycophenolate Mofetil and Daclizumab Immunosuppressor Regime |
| Lead sponsor | Sociedad Andaluza de Trasplantes de Organos y Tejidos, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Diseases, Graft Rejection |
| Intervention type | Drug |
| Interventions | Tacrolimus, Rapamycin |
| Enrollment | 94 |
| First posted | Feb 10, 2006 |
| Last update posted | May 15, 2007 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: